HCPCS code J9051: Bortezomib injection, MAIA product, per 0.1 mg2026 Medicare rate & RVUs

Bortezomib injection for multiple myeloma or mantle cell lymphoma, reported for the MAIA product in 0.1 mg units.

CMS RVU26DEffective Oct 1, 2026109 payment localities

Medicare rate · J9051

Bortezomib injection, MAIA product, per 0.1 mg

Office or facility?

Work RVUs
0
Total RVUs
0.00
Global days
XXX

National rate · 2026

—

Not priced in the facility setting.

See every locality for J9051 →Billed by an NP, PA or therapist? →

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

Your location

Medicare pays by the payment locality where the service is performed.

On this page 10 sections
  1. Medicare rate
  2. What J9051 covers
  3. By payment locality
  4. Rate map
  5. How it’s calculated
  6. Payment rules
  7. Similar codes
  8. Related codes
  9. Billing questions
  10. Sources

What J9051 covers

J9051 identifies injectable bortezomib associated with the MAIA product. Bortezomib is used in oncology treatment, including for multiple myeloma and mantle cell lymphoma, and may be administered intravenously or subcutaneously. The code distinguishes this product from other bortezomib products; use it when this product is administered.

CMS assigns status E, excluding the drug from the physician fee schedule. When Medicare covers it, payment is handled under another method; the HCPCS pricing method identifies it as a Part B drug generally priced from CMS quarterly ASP drug files. Coverage is left to the Medicare contractor's judgment. Each billing unit represents 0.1 mg of bortezomib, so the number of units reflects the administered dose divided by 0.1 mg.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J9051 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

J9051 office and facility rates by payment locality
Payment localityOfficeFacility
AlabamaUnavailableUnavailable
AlaskaUnavailableUnavailable
ArizonaUnavailableUnavailable
ArkansasUnavailableUnavailable
Atlanta, GAUnavailableUnavailable
Austin, TXUnavailableUnavailable
Bakersfield, CAUnavailableUnavailable
Baltimore area, MDUnavailableUnavailable
Beaumont, TXUnavailableUnavailable
Brazoria, TXUnavailableUnavailable

J9051 rates by state

Office rate range in each state. Select a state to see its payment localities.

Explore a state

Local rates. Clear comparisons.

Hover or focus a tile to see its rate range. Select it to open the state’s fee schedule.

View every state and territory as a table
J9051 office rate range by state
State / territoryOffice rate rangeLocalities
AKNo published base rate1
ALNo published base rate1
ARNo published base rate1
AZNo published base rate1
CANo published base rate29
CONo published base rate1
CTNo published base rate1
DCNo published base rate1
DENo published base rate1
FLNo published base rate3
GANo published base rate2
GUNo published base rate1
HINo published base rate1
IANo published base rate1
IDNo published base rate1
ILNo published base rate4
INNo published base rate1
KSNo published base rate1
KYNo published base rate1
LANo published base rate2
MANo published base rate2
MDNo published base rate3
MENo published base rate2
MINo published base rate2
MNNo published base rate1
MONo published base rate3
MSNo published base rate1
MTNo published base rate1
NCNo published base rate1
NDNo published base rate1
NENo published base rate1
NHNo published base rate1
NJNo published base rate2
NMNo published base rate1
NVNo published base rate1
NYNo published base rate5
OHNo published base rate1
OKNo published base rate1
ORNo published base rate2
PANo published base rate2
PRNo published base rate1
RINo published base rate1
SCNo published base rate1
SDNo published base rate1
TNNo published base rate1
TXNo published base rate8
UTNo published base rate1
VANo published base rate2
VINo published base rate1
VTNo published base rate1
WANo published base rate2
WINo published base rate1
WVNo published base rate1
WYNo published base rate1

How the J9051 rate is calculated

Each of J9051’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

How the rate is built · J9051

RVUs × geographic indexes × conversion factor

Office or facility?

Work0.00

0.00 RVUs× 1.000 GPCI

Practice expense0.00

0.00 RVUs× 1.000 GPCI

Malpractice0.00

0.00 RVUs× 1.000 GPCI

Adjusted RVUs

0.0000

Conversion factor

$33.4009

Medicare rate

$0.00

Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.

Payment rules and modifiers for J9051

J9051 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

Place of service · J9051

Which rate does Medicare pay?

The POS code on the claim line (CMS-1500 box 24B).

POS 11 · non-facility rate · national

—

J9051 isn’t priced in this setting.

J9051 compared with similar codes

Compare codes · National

4 codes, side by side

Office or facility?

  • J9051

    Bortezomib injection, MAIA product, per 0.1 mg0 wRVU

    Not priced

  • J9041

    Bortezomib injection, per 0.1 mg0 wRVU

    Not priced

  • J9048

    Bortezomib injection, fresenius Kabi, per 0.1 mg0 wRVU

    Not priced

  • J9054

    Bortezomib injection, boruzu, per 0.1 mg0 wRVU

    Not priced

How to choose

J9041Bortezomib injectionPer 0.1 mg
J9041 identifies a different bortezomib product. J9051 is specific to the MAIA product, which CMS identifies as not therapeutically equivalent to J9041.
J9048Bortezomib injectionFresenius Kabi, per 0.1 mg
J9048 identifies the Fresenius Kabi bortezomib product; J9051 identifies the MAIA product. Use the code matching the product administered.
J9054Bortezomib injectionBoruzu, per 0.1 mg
J9054 identifies Boruzu bortezomib, while J9051 identifies the MAIA product. These are separate product-specific codes.

J9051 billing questions

How is J9051 distinguished from J9041?

J9051 identifies the MAIA bortezomib product, while J9041 identifies a different product. CMS identifies J9051 as not therapeutically equivalent to J9041, so select the code for the product actually administered.

How many milligrams does one unit represent?

One unit represents 0.1 mg of bortezomib. Report units based on the administered dose.

Does status E mean Medicare never pays for J9051?

No. Status E excludes the drug from the physician fee schedule; when Medicare covers it, payment is under another method. The HCPCS pricing method identifies it as a Part B drug generally priced using CMS quarterly ASP drug files.

Who determines whether Medicare covers this drug?

Coverage is left to the Medicare contractor's judgment.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates

Did this answer your question about what J9051 pays?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put J9051 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist